These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6269636)

  • 1. Inhibition properties of Sepharose-bound trypsin and a protease on the surface of Ehrlich ascites tumour cells.
    Steven FS; Griffin MM; Itzhaki GS; Al-Habib A
    Biochim Biophys Acta; 1981 Aug; 660(2):333-40. PubMed ID: 6269636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A trypsin-like neutral protease on Ehrlich ascites cell surfaces: its role in the activation of tumour-cell zymogen of collagenase.
    Steven FS; Griffin MM; Itzhaki S; Al-Habib A
    Br J Cancer; 1980 Nov; 42(5):712-21. PubMed ID: 6257267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of free and bound trypsin-like enzymes.
    Steven FS; Griffin MM; Itzhaki S
    Eur J Biochem; 1982 Aug; 126(2):311-8. PubMed ID: 7128592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the zymogen of collagenase by Ehrlich-ascites-tumour-cell-surface trypsin-like enzyme.
    Steven FS; Griffin MM; Itzhaki S
    Biochem Soc Trans; 1980 Oct; 8(5):647-8. PubMed ID: 6256244
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the inhibition kinetics of trypsin in free solution and trypsin coupled to Sepharose-4B.
    Steven FS; Griffin MM
    Biochem Soc Trans; 1981 Feb; 9(1):145-6. PubMed ID: 7215648
    [No Abstract]   [Full Text] [Related]  

  • 6. Proteolytic activity associated with tumour growth and metastasis. Influence of trypsin inhibitor (soya bean) on Ehrlich ascites tumour growth [proceedings].
    Verloes R; Kanarek L
    Arch Int Physiol Biochim; 1976 Dec; 84(5):1119-20. PubMed ID: 66028
    [No Abstract]   [Full Text] [Related]  

  • 7. beta-Naphthylamidase activity of the cell surface of Ehrlich ascites cells. Reversible control of enzyme activity by metal ions and thiols.
    Short AK; Steven FS; Griffin MM; Itzhaki S
    Br J Cancer; 1981 Nov; 44(5):709-16. PubMed ID: 6797455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The export of a trypsin inhibitor from Ehrlich ascites cells that does not inhibit a trypsin-like enzyme on the surface of these cells.
    Steven FS; Griffin MM; Itzhaki S; Al-Habib A
    Biochem Soc Trans; 1980 Oct; 8(5):650-1. PubMed ID: 7450275
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for the presence of a trypsin inhibitor within rabbit and mouse tumour cells.
    Steven FS; Podrazky V; Itzhaki S
    Biochim Biophys Acta; 1977 Jul; 483(1):211-4. PubMed ID: 880306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cell-surface neutral protease of Ehrlich ascites tumor cells by potassium p-(3,3-dimethyl-1-triazeno) benzoate.
    Steven FS; Brown BS; Hulley TP; Itzhaki S; Giraldi T; Lassiani L
    Biochem Int; 1985 Aug; 11(2):153-60. PubMed ID: 3902023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of protease and protease inhibitors on the adhesion of Ehrlich ascites tumour cells to plastic.
    Whur P; Payne NE; Koppel H
    Exp Cell Res; 1974 Jun; 86(2):422-5. PubMed ID: 4842908
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for metal inhibition of tumour membrane-bound neutral protease and the control of tumour-induced target cell cytolysis.
    Steven FS; Hulley TP; Griffin MM; Itzhaki S
    Br J Cancer; 1982 Dec; 46(6):934-9. PubMed ID: 6185130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Displacement of trypsin from the tumour-cell inhibitor-trypsin complex by exchange, by using enzymes with blocked active centres [proceedings].
    Steven F; Podrazký V
    Biochem Soc Trans; 1978; 6(4):765-7. PubMed ID: 710711
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Independent responses of different binding sites on ehrlich ascites tumour cells to trypsin and trypsin inhibitor.
    Whur P; Payne NE; Koppel H
    Br J Cancer; 1974 Jan; 29(1):96. PubMed ID: 4820961
    [No Abstract]   [Full Text] [Related]  

  • 15. Properties of Ca2+-activated protease specific for the intermediate-sized filament protein vimentin in Ehrlich-ascites-tumour cells.
    Nelson WJ; Traub P
    Eur J Biochem; 1981 May; 116(1):51-7. PubMed ID: 7018903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of a trypsin-dependent neutral protease and its inhibitor found in tumour cells. Analysis of complex kinetic data involved in a thiol-disulphide exchange mechanism.
    Steven FS; Podrazký V; Itzhaki S
    Biochim Biophys Acta; 1978 May; 524(1):170-82. PubMed ID: 656442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition kinetics of a trypsin-like neutral proteinase on the surface of Ehrlich ascites-tumour cells.
    Steven FS; Griffin MM; Itzhaki S
    Biochem Soc Trans; 1981 Feb; 9(1):146-7. PubMed ID: 7011870
    [No Abstract]   [Full Text] [Related]  

  • 18. Similarity in active site arrangement of neutral protease from calf thymus chromatin and trypsin.
    Kowalska-Loth B; Zieleński J; Toczko K; Chmielewska I
    Acta Biochim Pol; 1976; 23(2-3):139-44. PubMed ID: 987680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in growth and adhesion of Ehrlich ascites tumour cells coated with trypsin inhibitor (soybean).
    Whur P; Robson RT; Payne NE
    Br J Cancer; 1973 Jul; 28(1):80. PubMed ID: 4737503
    [No Abstract]   [Full Text] [Related]  

  • 20. The reversible thiol-disulphide exchange of trypsin and chymotrypsinogen with a tumour-derived inhibitor. Kinetic data obtained with fluorescein-labelled polymeric collagen fibrils and casein as substrates.
    Steven FS; Podrazký V
    Biochim Biophys Acta; 1979 May; 568(1):49-58. PubMed ID: 444546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.